About Biogazelle
Biogazelle is a company based in Ghent (Belgium) founded in 2007 was acquired by CellCarta in December 2021.. Biogazelle has raised $3.7 million across 3 funding rounds from investors including CellCarta, European Union and Beste Online Casino België. The company has 20 employees as of December 31, 2019. Biogazelle offers products and services including Digital PCR, Quantitative PCR, RNA Sequencing, qbase+ Software, and Custom Primer Design. Biogazelle operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
- Headquarter Ghent, Belgium
- Employees 20 as on 31 Dec, 2019
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Biogazelle
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Biogazelle
Biogazelle offers a comprehensive portfolio of products and services, including Digital PCR, Quantitative PCR, RNA Sequencing, qbase+ Software, and Custom Primer Design. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Service for precise DNA and mutation detection in research.
Method for accurate gene expression and SNP genotyping.
Technique for analyzing RNA transcripts in samples.
qPCR analysis software for data processing and validation.
Service for designing primers for gene expression studies.
Funding Insights of Biogazelle
Biogazelle has successfully raised a total of $3.7M across 3 strategic funding rounds. The most recent funding activity was a Grant round of $559.83 thousand completed in January 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Grant — $559,826
-
First Round
First Round
(06 Oct 2014)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2020 | Amount | Grant - Biogazelle | Valuation |
investors |
|
| Aug, 2015 | Amount | Series A - Biogazelle | Valuation |
investors |
|
| Oct, 2014 | Amount | Series A - Biogazelle | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Biogazelle
Biogazelle has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include CellCarta, European Union and Beste Online Casino België. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Cancer research is supported through funding and entrepreneurial guidance.
|
Founded Year | Domain | Location | |
|
Venture capital fund investing in technological breakthroughs from universities.
|
Founded Year | Domain | Location | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Biogazelle
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Biogazelle
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biogazelle Comparisons
Competitors of Biogazelle
Biogazelle operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Small molecules are developed for cancer and skin disease treatments.
|
|
| domain | founded_year | HQ Location |
Cancer therapies are developed using selective pathway inhibitors.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Biogazelle
Frequently Asked Questions about Biogazelle
When was Biogazelle founded?
Biogazelle was founded in 2007 and raised its 1st funding round 7 years after it was founded.
Where is Biogazelle located?
Biogazelle is headquartered in Ghent, Belgium. It is registered at Ghent, East Flanders, Belgium.
Is Biogazelle a funded company?
Biogazelle is a funded company, having raised a total of $3.7M across 3 funding rounds to date. The company's 1st funding round was a Series A of $2.5M, raised on Oct 06, 2014.
How many employees does Biogazelle have?
As of Dec 31, 2019, the latest employee count at Biogazelle is 20.
What does Biogazelle do?
Biogazelle develops transcriptomics-based diagnostics and therapeutics. It offers Qbase, a software for managing qPCR in research laboratories by streamlining normalization, quality control and calibration between runs. Its proprietary platform sequences the entire transcriptome to identify RNA biomarker targets from clinically relevant samples. These biomarkers can be used to then develop qPCR based diagnostic tests. In addition, the company is developing RNA-based cancer therapies that work by silencing long non-coding RNA.
Who are the top competitors of Biogazelle?
Biogazelle's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
What products or services does Biogazelle offer?
Biogazelle offers Digital PCR, Quantitative PCR, RNA Sequencing, qbase+ Software, and Custom Primer Design.
Who are Biogazelle's investors?
Biogazelle has 5 investors. Key investors include CellCarta, European Union, Beste Online Casino België, Foundation Fournier-Majoie, and Qbic Venture Partners.